The Promise and Peril of Antibody Testing for COVID-19.JAMA. 2020 May 19; 323(19):1881-1883.JAMA
Links
MeSH
Antibodies, ViralBetacoronavirusCOVID-19COVID-19 TestingClinical Laboratory TechniquesCommunicable Disease ControlCoronavirus InfectionsFalse Negative ReactionsHumansImmunoglobulin GImmunoglobulin MMass ScreeningPandemicsPneumonia, ViralPoint-of-Care TestingPopulation SurveillanceSARS-CoV-2Sensitivity and Specificity
Pub Type(s)
News
Language
eng
PubMed ID
32301958
Citation
Abbasi, Jennifer. "The Promise and Peril of Antibody Testing for COVID-19." JAMA, vol. 323, no. 19, 2020, pp. 1881-1883.
Abbasi J. The Promise and Peril of Antibody Testing for COVID-19. JAMA. 2020;323(19):1881-1883.
Abbasi, J. (2020). The Promise and Peril of Antibody Testing for COVID-19. JAMA, 323(19), 1881-1883. https://doi.org/10.1001/jama.2020.6170
Abbasi J. The Promise and Peril of Antibody Testing for COVID-19. JAMA. 2020 May 19;323(19):1881-1883. PubMed PMID: 32301958.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The Promise and Peril of Antibody Testing for COVID-19.
A1 - Abbasi,Jennifer,
PY - 2020/4/18/pubmed
PY - 2020/9/25/medline
PY - 2020/4/18/entrez
SP - 1881
EP - 1883
JF - JAMA
JO - JAMA
VL - 323
IS - 19
SN - 1538-3598
UR - https://www.unboundmedicine.com/medline/citation/32301958/full_citation
L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6170
DB - PRIME
DP - Unbound Medicine
ER -